Clinical Trial Update: Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the immunogenicity and safety of four formulations of the GlaxoSmithKline MenACWY-TT meningococcal conjugate vaccine in children; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Infections

Drugs mentioned

• MenACWY-TT Conjugate Vaccine (Meningococcal ACWY conjugate vaccine (tetanus toxoid conjugate))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 2 | Status: COMPLETED